Navigate Up
Sign In
Launch the Developer Dashboard
Skip navigation links

News and Announcements


By-laws


Commissioners


Self-Study Guidelines


Standards for Doctoral Programs


Standards for Postdoctoral Programs


Training Programs


Links


ComACC Home

The University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center 

 

Director:

Contact Address:

 

Qing H Meng, MD, PhD, DABCC, FCACB, FACB
Professor of Laboratory Medicine
Director of Clinical Chemistry
Telephone: 713-792-6320
Fax: 713-792-4793
E-mail:  qhmeng@mdanderson.org

Department of Laboratory Medicine,
The University of Texas MD Anderson Cancer Center,
1515 Holcombe Boulevard, R4.1441G, Unit 37
Houston, Texas 77030
 

Faculty and Research Interests


University of Texas MD Anderson Cancer Center

Qing H. Meng, MD, PhD, DABCC, FACB

Clinical Chemistry, Immunoassay, Tumor Markers, TDM

Beverly C. Handy, MD

Clinical Chemistry, Protein Electrophoresis

Elizabeth A. Wagar, MD

Laboratory Administration and Quality Management

Rajyalakshmi Luthra, PhD

Molecular Diagnostics

Xiaoping Sun , MD, PhD

Hematology and Coagulation

Xin Han, MD

Point of Care Testing

Kai Cao, PhD

HLA, Immunology

Xiang-Yang Han, MD, PhD

Microbiology and Molecular Diagnostics

Ping Wang, PhD, DABCC, FACB

Chemistry, Toxicology, Pharmacogenomics (The Methodist Hospital)

Sridevi Devaraj, PhD, DABCC, FACB

Pediatric Chemistry (Texas Children's Hospital)

Program Listing:

Level(s) of training: Post-doctoral
Number of positions available per year: 1 every two years
Duration of program: 2 years
Approximate annual salary or stipend: PGY2/3
Source of funding: Departmental
Current number of trainees:
1
Number of past graduates: N/A
Date of ComACC accreditation: July 2014

Application Procedures:


Prerequisites:

The applicant should hold a PhD or MD in Medical Sciences and have adequate education in basic life sciences including chemistry, biochemistry or pharmacology from an accredited University at the graduate level. Applicants with education obtained at institutions outside the U.S. or Canada must have their credentials evaluated for equivalency. Candidates must have completed a minimum of 30 semester hours in chemistry or biochemistry courses required for ABCC certification. Applicants should have strong interests in laboratory medicine.

Procedures:

Applicants should submit a letter of interest and include their curriculum vitae to the program director. Upon notification, applicants will be required to submit their undergraduate/graduate transcripts and three letters of recommendation to the program director and coordinator.

Deadline:

September 30 of year preceding appointment on July 1


Program Description

The University of Texas MD Anderson Cancer Center is one of the leading comprehensive cancer centers in the United States. It is both a degree-granting academic institution and a cancer treatment and research center located at the Texas Medical Center in Houston, Texas. The Department of Laboratory Medicine offers a two-year training program in chemical chemistry to provide PhD scientists with analytical, clinical, research, and management experience towards the American Board of Clinical Chemistry (ABCC) certification in clinical chemistry. MD Anderson's Clinical Chemistry area performs over eight million tests each year. The program is designed to provide training in the operation of a clinical laboratory, analytical methodologies, instrument/method selection and evaluation, therapeutic drug monitoring, molecular diagnostics, point-of-care testing, quality control and assurance, and laboratory management and regulations. Test interpretation and clinical consultation are especially emphasized. Research projects involving method development or validation, error investigation, translational and clinical studies related to clinical chemistry are required. Fellows join training with clinical pathology residents and gain more knowledge and understanding of the pathophysiology of diseases and clinical diagnosis. In addition, this program offers special opportunity to gain experience in the area of tumor markers and other cancer-related testing. The first year of the program focuses on laboratory rotation in the area of clinical chemistry, special chemistry, TDM, and molecular diagnostics. The second year of training is to conduct consultation, quality management, and research projects. Upon completion of the program, fellows are expected to take the ABCC examination.

​​​​​http://www.mdanderson.org/education-and-research/education-and-training/schools-and-programs/graduate-medical-education/residency-and-fellowship-programs/clinical-chemistry-fellowship.html